Based on our advanced algorithm, we predict that ZLAB stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $38, while the 1-week outlook suggests a value of $38. For the 1-month forecast, we project a price of $41. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ZLAB has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
ZLAB stock price ended at $37 on Tuesday, after rising6.75%
The Zai Lab Ltd stock price increased by 6.75% on the last trading day (22 Jul 2025), rising from 37.5 to 37. Throughout the last trading session, the stock experienced a fluctuation of 6.51% , ranging from a day low of $36.4 to a day high of 38.77. The price has declined in 3 of the last 10 days, resulting in a total change of 5.90% during this period. On the last day, trading volume decrease by 820.67K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.80M shares were traded, amounting to approximately 66.72M.
ZLAB Technical Signals
ZLAB(Zai Lab Ltd Corp) has 4 buy signals and 3 sell signals now. The current trend is consolidation starting from 2025-07-11. The total price change during this trend is +13.05%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of ZLAB over the last 5 trading days is 37.25M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
ZLAB Moving Average Analysis
Zai Lab Ltd's overall moving average trend leans more bullish as of Wednesday, July 23, 2025, with 0 negative signals and 4 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $39.31, and $41.78. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $31.32, and $28.85. A break-down below any of these levels will issue sell signals.
ZLAB Short Selling Analysis
The short sale ratio of Zai Lab Ltd(ZLAB) as of 17 Jul 2025 is 15.95%, rising from last trading day. With increasing price from 35.47 to 36.01. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Neutral
Sell
3
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
2.06
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
Moving Average
Price crosses above 20-day SMA
--
Bullish
Moving Average
5-day SMA crosses above 20-day SMA
--
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Zai Lab Ltd (ZLAB) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Zai Lab Ltd Stock Forecast 2026
ZLAB Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Zai Lab Ltd(ZLAB), our algorithm predicts ZLAB's 1-month price at $34.35, with an 2.31%upwardshift. Using a similarity score up to 93.73%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Zai Lab Ltd (ZLAB.O) stock, as of Sunday, July 20, 2025 , forecasts a 2.31% change over the next month, based on its high correlation with DALN.O stock patterns. The similarity between their price movements over the analyzed periods is 93.73%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
ZLAB
Future prediction
Up: 2.31%
DALN
Up: 2.31%Similarity: 93.73%
Name
Similarity
Up/Down
DALN.O
93.73%
+2.31%
BTU.N
93.47%
-5.24%
OGS.N
93.43%
-0.79%
NMTC.O
93.42%
+11.46%
UXIN.O
93.38%
-40.93%
PARR.N
93.29%
+5.30%
OXBR.O
93.22%
-8.15%
IFBD.O
93.20%
-35.91%
CYCU.O
93.17%
-9.18%
CVR.A
93.14%
-0.56%
ZLAB Seasonality Analysis
Based on ZLAB's historical stock price data across all years, the probability of a positive return in July is50.00%, suggesting it maybe an ideal month to invest in ZLAB. In contrast,Januaryoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Zai Lab Ltd (ZLAB.O) stock in January has the highest probability of a positive return (75.00%), while March has the lowest probability (25.00%).
Performance Seasonality
The chart shows Zai Lab Ltd. (ZLAB)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ZLAB has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Zai Lab Ltd (ZLAB.O) stock in a year?
The radar chart shows that buying Zai Lab Ltd (ZLAB.O) stock in January has the highest probability of a positive return (75.00%), while March has the lowest probability (25.00%).
How has Zai Lab Ltd. (ZLAB)'s stock price performed over the past three years?
ZLAB's stock price fell by -11.38% in 2023,increased by 0.50% in 2024, and went up by 49.13%in 2025.
Is ZLAB a buy based on overall technical signals summary?
ZLAB has 4 buy signals and 3 sell signals now. Overall the technical rating for ZLAB is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ZLAB.
What is the trend of Zai Lab Ltd (ZLAB)'s moving average?
Zai Lab Ltd's overall moving average trend leans more bullish as of July 23 2025, with 0 negative signals and 4 positive signal.
What is price prediction for ZLAB stock next month?
The price prediction chart for Zai Lab Ltd (ZLAB.O) stock, as of July 20 2025, forecasts a 2.31% change over the next month, based on its high correlation with DALN stock patterns. The similarity between their price movements over the analyzed periods is 93.73%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for ZLAB Stock?
ZLAB stock is predicted to reach **$42** by the end of 2025, driven by positive Phase 3 trial results for pancreatic cancer treatment. The stock shows strong momentum but may face short-term corrections due to overbought conditions.
What is price prediction 2030 for ZLAB Stock?
Zai Lab (ZLAB) stock is predicted to reach **$60 by 2030**, driven by its strong pipeline in oncology and immunology, with potential upside from successful clinical trials and market expansion. However, if growth slows or drug trials underperform, the price could stabilize around **$40**. The most likely scenario is **$50**, balancing biotech volatility and therapeutic potential.